Fadi Azar is an experienced Project Engineer currently working at Transgene since May 2019, focusing on the development and optimization of innovative immunotherapies for solid cancers through in vitro and in vivo testing. Previously, Fadi held roles at Université de Montpellier, where responsibilities included assessing gas tolerance in mice and Caenorhabditis elegans, and conducting toxicity and carcinogenicity testing. Fadi also worked at Sanofi as an apprentice, where expertise was developed in preparing and testing Zebrafish larvae for bioanalysis related to convulsant potential. Educational qualifications include a Master 2 in Non-clinical R&D of healthcare products from the University of Montpellier and an Animal Experimentation Accreditation from Ecole nationale vétérinaire de Nantes.